Prestige Consumer Healthcare (PBH) Retained Earnings (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Retained Earnings of $1.7 billion for Q4 2025, up 12.39% year-over-year from $1.5 billion in Q4 2024, and up 2.84% quarter-over-quarter from $1.6 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Retained Earnings (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Retained Earnings history runs 15 years deep, the most recent figure standing at $1.7 billion for Q4 2025.
- In Q4 2025, Retained Earnings rose 12.39% year-over-year to $1.7 billion; the TTM figure through Dec 2025 stood at $1.7 billion (up 12.39% YoY), while the FY2025 annual figure was $1.6 billion, up 16.0% from the prior year.
- Retained Earnings for Q4 2025 stood at $1.7 billion, up from $1.6 billion in the prior quarter.
- The five-year high for Retained Earnings was $1.7 billion in Q4 2025, with the low at -$36.0 million in Q3 2023.
- The 5-year median for Retained Earnings is $1.2 billion (2022), against an average of $871.5 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings soared 6231.83% in 2022, then slumped 106.86% in 2023.
- Prestige Consumer Healthcare's Retained Earnings stood at -$23.2 million in 2021, then soared by 6013.78% to $1.4 billion in 2022, then plunged by 102.08% to -$28.5 million in 2023, then jumped by 5377.7% to $1.5 billion in 2024, then rose by 12.39% to $1.7 billion in 2025.
- Business Quant data shows PBH's Retained Earnings at $1.7 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 3.75 Bn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | 1.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.75 Bn |
| Dec 31, 2025 | 1.69 Bn |
| Sep 30, 2025 | 1.65 Bn |
| Jun 30, 2025 | 1.60 Bn |
| Mar 31, 2025 | 1.56 Bn |
| Dec 31, 2024 | 1.51 Bn |
| Sep 30, 2024 | 1.44 Bn |
| Jun 30, 2024 | 1.39 Bn |
| Mar 31, 2024 | 1.34 Bn |
| Dec 31, 2023 | -28.53 Mn |
| Sep 30, 2023 | -35.99 Mn |
| Jun 30, 2023 | -32.21 Mn |
| Mar 31, 2023 | -31.56 Mn |
| Dec 31, 2022 | 1.37 Bn |
| Sep 30, 2022 | 524.39 Mn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | -23.21 Mn |
| Sep 30, 2021 | -24.42 Mn |
| Jun 30, 2021 | 1.07 Bn |